Back to Market返回行情

SUNPHARMA.BO Sun Pharmaceutical Industries Limited

BSEHealthcare

$1,789.45-0.03%OpenMarket Cap: $4.29T

As of 2026-06-03 06:14

Valuation

P/E (TTM)

37.42

PEG

—

P/B

5.14

P/S

7.34

EV/EBITDA

25.79

DCF Value

—

FCF Yield

0.6%

Div Yield

0.9%

Margins & Returns

Gross Margin

55.7%

Operating Margin

23.2%

Net Margin

19.6%

ROE

15.0%

ROA

10.6%

ROIC

11.5%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2026	$146.12B	55.3%	$27.52B	$27.14B	$11.30	—
Q3 2026	$155.21B	57.7%	$40.62B	$33.69B	$14.04	—
Q2 2026	$144.78B	55.3%	$33.67B	$31.18B	$13.00	—
Q1 2026	$138.51B	54.4%	$33.72B	$22.79B	$9.50	—
Q4 2025	$129.59B	73.4%	$61.54B	$21.50B	$9.00	—
Q3 2025	$136.75B	80.0%	$75.58B	$29.03B	$12.10	—
Q2 2025	$132.91B	79.7%	$73.57B	$30.40B	$12.70	—
Q1 2025	$126.53B	78.9%	$67.47B	$28.36B	$11.82	—
Q4 2024	$119.83B	73.6%	$55.58B	$26.55B	$11.10	—
Q3 2024	$123.81B	77.9%	$64.69B	$25.24B	$10.52	—
Q2 2024	$121.92B	77.1%	$62.85B	$23.76B	$9.90	—
Q1 2024	$119.41B	76.9%	$61.12B	$20.23B	$8.43	—